机器人辅助与腹腔镜远端胃切除术在新辅助化疗后进展期胃癌中的安全性与疗效比较
本研究回顾性分析2020年2月至2022年3月接受新辅助化疗后行机器人辅助远端胃切除术(RADG)或腹腔镜远端胃切除术(LDG)的进展期胃癌(cT3-4a/N+)患者,经倾向性评分1:1匹配后每组67例。RADG组术中出血量更少、淋巴结检出数更多,术后疼痛评分更低、下床活动和排气更早、住院时间更短,手术时间和术后并发症无显著差异。RADG可能是新辅助化疗后进展期胃癌的潜在治疗选择。
要点
- RADG组术中出血量显著少于LDG组(35.6 vs. 118.8 ml,P=0.014)。
- RADG组淋巴结检出总数、胃周外及胰上淋巴结检出数均显著多于LDG组。
- RADG组术后24h VAS评分更低、下床活动及排气更早、住院时间更短。
核心结论
- 对于新辅助化疗后的进展期胃癌患者,RADG在围术期指标方面优于LDG,可能是潜在的治疗选择。
研究设计与样本
- 回顾性倾向性评分匹配分析,纳入2020年2月至2022年3月接受新辅助化疗后行RADG或LDG的进展期胃癌(cT3-4a/N+)患者,按1:1匹配后每组67例。
主要发现
- RADG组术中出血量低于LDG组(35.6 vs. 118.8 ml,P=0.014)。
- RADG组淋巴结检出总数多于LDG组(50.7 vs. 39.5,P<0.001),胃周外淋巴结(18.3 vs. 10.4,P<0.001)和胰上淋巴结(16.33 vs. 13.70,P=0.042)检出数亦更多。
- RADG组术后24h VAS评分更低(2.2 vs. 3.3,P=0.034),下床活动更早(1.3 vs. 2.6,P=0.011),排气时间更早(2.2 vs. 3.6,P=0.025),术后住院时间更短(8.3 vs. 9.8,P=0.004)。
- 两组手术时间(216.7 vs. 194.7 min,P=0.204)和术后并发症无显著差异。
临床怎么用
- 在新辅助化疗后的进展期胃癌患者中,RADG可减少术中出血、提高淋巴结检出数并加速术后恢复,可作为LDG的替代选择之一。
局限性
- 本研究为单中心回顾性分析,样本量有限(匹配后每组67例),结论需前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robot-assisted distal gastrectomy (RADG) has been used in the minimally invasive surgical treatment of gastric cancer, but the research on advanced gastric cancer (AGC) after neoadjuvant chemotherapy (NAC) has not been reported. This study aimed to analyze the outcomes of RADG versus laparoscopic distal gastrectomy (LDG) after NAC for AGC. METHODS: This was a retrospective propensity score-matched analysis from February 2020 and March 2022. Patients who underwent RADG or LDG for AGC (cT3-4a/N +) following NAC were enrolled and a propensity score-matched analysis was performed in a 1:1 manner. The patients were divided into RADG group and LDG group. The clinicopathological characteristics and short-term outcomes were observed. RESULTS: After propensity score matching, 67 patients each in the RADG and LDG groups. RADG was associated with a lower intraoperative blood loss (35.6 vs. 118.8 ml, P = 0.014) and more retrieved lymph nodes (LNs) (50.7 vs. 39.5, P < 0.001), more extraperigastric (18.3 vs. 10.4, P < 0.001), and suprapancreatic LNs (16.33 vs. 13.70, P = 0.042). The RADG group showed lower VAS scores at postoperative 24 h (2.2 vs 3.3, P = 0.034), earlier ambulation (1.3 vs. 2.6, P = 0.011), aerofluxus time (2.2 vs. 3.6, P = 0.025), and shorter postoperative hospital stay (8.3 vs. 9.8, P = 0.004). There were no significant differences in the operative time (216.7 vs.194.7 min, P = 0.204) and postoperative complications between the two groups. CONCLUSION: RADG may be a potential therapeutic option for patients with AGC after NAC considering its advantages in perioperative period compared with LDG.
引用
- Tian Y, Guo H, Hu Y, et al. Safety and efficacy of robotic-assisted versus laparoscopic distal gastrectomy after neoadjuvant chemotherapy for advanced gastric cancer. Surg Endosc. 2023. PMID: 37221415. doi:10.1007/s00464-023-10122-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。